L

LNC Therapeutics

24 employees

LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Obesity
Cardiometabolic diseases
Life Science
Microbiome
Cardiometabolism
Biopharma
Microbiota
Gut microbiota
Gut modulator

Date founded

2010

Funding rounds raised

Total raised

$7.6M

from 5 investors over 5 rounds

L

LNC Therapeutics raised $6.9M on September 5, 2019

Investors: Seventure Partners

L

LNC Therapeutics raised $7.6M on September 27, 2017

Investors: Seventure Partners

L

LNC Therapeutics raised $4.6M on April 12, 2012

Investors: AQUITI Gestion, GSO Capital Partners and Seventure Partners

FAQ